Whole-genome sequence and functional annotation dataset of a proteolytic bacterium, <i>Deinococcus wulumuqiensis</i> FBCC-B5220. [PDF]
Choi A, Goh J, Hwang Y, Lee MH.
europepmc +1 more source
Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin +3 more
wiley +1 more source
Development of Replicon Cell Pools Bearing a Flavivirus RNA Replicon as a Source of HIV-1 Gag-Pol for Lentiviral Vector Production. [PDF]
Kydyrbayeva A +8 more
europepmc +1 more source
Proteolytic control of mitochondrial protein translocases. [PDF]
Kroczek L, Langer T.
europepmc +1 more source
SsPit2A/B Effectors from <i>Sporisorium scitamineum</i> Interact with the Sugarcane PLCP ScRD21A and Reduce ScRD21A-Associated Cysteine Protease Activity via a Conserved LXRR Motif. [PDF]
Zhu Y +7 more
europepmc +1 more source
TFPI2 in tumor metastasis: a double-edged sword with clinical implications. [PDF]
Guo Z +9 more
europepmc +1 more source
Conkazal-M1 from the MKAVA family of conotoxins: A dual-function protease inhibitor and neuroactive peptide. [PDF]
Hackney CM +12 more
europepmc +1 more source
Serine Protease HtrA2 from Halophilic Archeon <i>Haloarcula</i> sp. TG1: Heterologous Expression, Characterization and Immobilization. [PDF]
Kurt-Kızıldoğan A +5 more
europepmc +1 more source
Related searches:
Proteases, proteases and proteases for presentation
Nature Immunology, 2003Peptide epitope generation for MHC class I presentation is normally dependent upon proteasome activity. Yet this pathway fails to generate critical HIV epitopes. Instead, the protease TPPII is required for this activity.
Herberts, Carla +2 more
openaire +2 more sources

